Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Total Debt (2023 - 2025)

Historic Total Debt for Q32 Bio (QTTB) over the last 3 years, with Q3 2025 value amounting to $11.2 million.

  • Q32 Bio's Total Debt fell 1087.75% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year decrease of 1087.75%. This contributed to the annual value of $12.7 million for FY2024, which is 13178.24% up from last year.
  • According to the latest figures from Q3 2025, Q32 Bio's Total Debt is $11.2 million, which was down 1087.75% from $12.8 million recorded in Q2 2025.
  • Q32 Bio's Total Debt's 5-year high stood at $12.8 million during Q2 2025, with a 5-year trough of $5.5 million in Q4 2023.
  • Over the past 3 years, Q32 Bio's median Total Debt value was $12.6 million (recorded in 2024), while the average stood at $11.6 million.
  • As far as peak fluctuations go, Q32 Bio's Total Debt soared by 13178.24% in 2024, and later plummeted by 1087.75% in 2025.
  • Over the past 3 years, Q32 Bio's Total Debt (Quarter) stood at $5.5 million in 2023, then soared by 131.78% to $12.7 million in 2024, then dropped by 11.22% to $11.2 million in 2025.
  • Its Total Debt was $11.2 million in Q3 2025, compared to $12.8 million in Q2 2025 and $12.7 million in Q1 2025.